These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22349527)

  • 1. Inflammation and ovarian cancer.
    Macciò A; Madeddu C
    Cytokine; 2012 May; 58(2):133-47. PubMed ID: 22349527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokines in inflammation].
    Cavaillon JM
    C R Seances Soc Biol Fil; 1995; 189(4):531-44. PubMed ID: 8564567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of proinflammatory cytokines from inflamed porcine uterus into the uterine venous blood--preliminary data.
    Kucharski J; Stefańczyk-Krzymowska S; Jana B
    Pol J Vet Sci; 2008; 11(1):9-16. PubMed ID: 18540202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
    Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
    Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear leucocytes selectively produce anti-inflammatory interleukin-1 receptor antagonist and chemokines, but fail to produce pro-inflammatory mediators.
    Schröder AK; von der Ohe M; Kolling U; Altstaedt J; Uciechowski P; Fleischer D; Dalhoff K; Ju X; Zenke M; Heussen N; Rink L
    Immunology; 2006 Nov; 119(3):317-27. PubMed ID: 17067311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
    Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
    J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
    Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
    J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.
    Nanji AA; Jokelainen K; Rahemtulla A; Miao L; Fogt F; Matsumoto H; Tahan SR; Su GL
    Hepatology; 1999 Oct; 30(4):934-43. PubMed ID: 10498645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer.
    Madhusudan S; Muthuramalingam SR; Braybrooke JP; Wilner S; Kaur K; Han C; Hoare S; Balkwill F; Ganesan TS
    J Clin Oncol; 2005 Sep; 23(25):5950-9. PubMed ID: 16135466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks.
    Naldini A; Morena E; Belotti D; Carraro F; Allavena P; Giavazzi R
    Thromb Haemost; 2011 Oct; 106(4):705-11. PubMed ID: 21833453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of inflammatory cytokines produced by gingival fibroblasts after human cytomegalovirus infection.
    Botero JE; Contreras A; Parra B
    Oral Microbiol Immunol; 2008 Aug; 23(4):291-8. PubMed ID: 18582328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
    Gordon IO; Freedman RS
    Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meconium is a source of pro-inflammatory substances and can induce cytokine production in cultured A549 epithelial cells.
    de Beaufort AJ; Bakker AC; van Tol MJ; Poorthuis BJ; Schrama AJ; Berger HM
    Pediatr Res; 2003 Oct; 54(4):491-5. PubMed ID: 12840156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.
    Watson JM; Sensintaffar JL; Berek JS; Martínez-Maza O
    Cancer Res; 1990 Nov; 50(21):6959-65. PubMed ID: 2208162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma.
    Chen LL; Ye F; Lü WG; Yu Y; Chen HZ; Xie X
    J Obstet Gynaecol Res; 2009 Apr; 35(2):212-8. PubMed ID: 19335794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation: a hidden path to breaking the spell of ovarian cancer.
    Shan W; Liu J
    Cell Cycle; 2009 Oct; 8(19):3107-11. PubMed ID: 19738436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.